MEBI: risk of serious health complaints from Rebound HRD® inguinal hernia mesh The Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI), which is part of RIVM, has received a report about Rebound HRD® (Hernia Repair Device), an inguinal hernia mesh.
295 reports of suspected side effects of implants in 2023 In 2023, 295 individuals reported one or more suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI).
MEBI: 193 reports of suspected side effects of implants in 2022 In 2022, 193 individuals reported suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI). Most reports received concerned breast implants, copper IUDs and wrinkle fillers. This is highlighted in MEBI’s annual report.
Can you solve a medical mystery? During World Antibiotic Awareness Week 2019, RIVM has set up an escape room in one of busiest shopping malls in the Netherlands.
New standard for exposure assessment of cleaning products RIVM has updated the standard for exposure assessment of cleaning products in the ConsExpo Cleaning Products Fact Sheet.
RIVM launches new web-based version of ConsExpo An improved version of the computer program ConsExpo is now available via the RIVM website.
Bacteria slightly more often resistant to last resort antibiotics Antimicrobial resistance is a global problem. In the Netherlands, some bacteria that can cause infections in people are more frequently resistant to antibiotics used as a last resort.
European Antibiotic Awareness Day: the fight against antibiotics resistance Wednesday, 18 November is European Antibiotic Awareness Day. On this day, attention throughout Europe is requested for the responsible use of antibiotics in people and animals.
CAESAR annual report 2014 The World Health Organization (WHO) published its first CAESAR annual report 2014.
Antibiotic resistance is stable, however, more resistant bacteria are expected Over recent years, antibiotic resistance to most agents has remained stable in the Netherlands, and the use of antibiotics has slightly decreased.